Product information and disease descriptionProduct descriptionProduct information
American hospital formulary service (AHFS), or other drug classification
3 evidence topics · 2 sources
AHFS classification
No evidence found.
ATC classification
No evidence found.
USP category and class
No evidence found.
Pharmacologic class stated in the prescribing information
KEGG DRUG classification
| Field | Quoted record |
|---|---|
| Efficacy | “Antiviral” |
| Type | “Antisense oligonucleotide” |
| Comment | “Treatment of hepatitis B virus (HBV) infection” |
| Target | “HBV mRNA” |
| Brite hierarchy, level 1 | “Antimicrobials” |
| Brite hierarchy, level 2 | “Antivirals” |
| Brite hierarchy, level 3 | “Polyprotein cleavage inhibitor” |
| Brite hierarchy, level 4 | “HBV mRNA antisense” |
Therapeutic category of drugs in Japan
| Field | Quoted record |
|---|---|
| Therapeutic category code | “6250” |
| Category, level 1 | “Agents against pathologic organisms and parasites” |
| Category, level 2 | “Chemotherapeutics” |
| Category, level 3 | “Antivirals” |